Frank Mottola - 05 Mar 2025 Form 4 Insider Report for SUPERNUS PHARMACEUTICALS, INC. (SUPN)

Role
SVP, Quality, GMP, Ops, IT
Signature
/s/ Timothy C. Dec, as attorney-in-fact
Issuer symbol
SUPN
Transactions as of
05 Mar 2025
Net transactions value
-$62,531
Form type
4
Filing time
05 Mar 2025, 16:19:15 UTC
Previous filing
26 Feb 2025
Next filing
07 Mar 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SUPN Common Stock Tax liability $11,138 -337 -2.1% $33.05 15,437 05 Mar 2025 Direct F1
transaction SUPN Common Stock Tax liability $20,160 -610 -4% $33.05 14,827 05 Mar 2025 Direct F1
transaction SUPN Common Stock Tax liability $31,232 -945 -6.4% $33.05 13,882 05 Mar 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the vesting of Restricted Stock Units.